glp-1 patent Patents and regulatory exclusivities on receptor agonists Looming GLP-1 drug patent expirations

Greater Convenience Oral medications such as Orforglipron may improve patient compliance and accessibility

Telehealth has transformed access to weight loss medications, allowing patients to consult licensed providers from home and receive prescriptions for GLP-1 therapies

Freezing at -20C extends this further

In a high-fat diet (HFD)-induced mouse model of obesity, OG demonstrated superior efficacy in suppressing weight gain, reducing food intake, and improving metabolic parameters, including fasting blood glucose, oral glucose tolerance, and insulin sensitivity, compared to orally administered allicin oleogel (OGO) and metformin (MET)

Material is supplied lyophilised and should be stored as stated on the batch documentation

doi: 10.1073/pnas.0306981100 127 FanWWaizeneggerWLinCSSorrentinoVHeMXWallCEet al